Full Name
Dr. Laura Squire
Job Title
Chief Healthcare Quality and Access Officer
Company
MHRA
Speaker Bio
Laura is currently seconded from her main role as Chief Healthcare Quality and Access Officer. Healthcare Quality and Access (HQ&A) is a large portfolio that is designed to ensure the quality and access of products to the UK market - this includes scientific advice, clinical trials/clinical investigations, licensing assessment, marketing authorisations and device registrations, inspections, enforcement and standard setting through for example the British Pharmacopoeia and Target Product Profiles.
Within the HQ&A portfolio is the work to reform the regulatory framework for Medical Devices in the UK. Because of the priority of this work, for device patient access in the UK, and achievement of the UK Life Sciences Vision, Laura has been seconded to focus solely on this work. This includes leading interactions with IMDRF, and our Software and AI team who have a very productive partnership with the FDA Digital Centre of Excellence.
Laura started her career as a post-doctoral research assistant looking at resistance to anti-malarial drugs at the Liverpool Institute of Tropical Medicine following her PhD and BSc in Biochemistry and Physiology. She has spent most of her career as a Civil Servant. After many years in operational work Laura moved into government policy in 2014. In parallel, she went back to university, gaining an Executive Master’s degree in Public Policy from the London School of Economics. Laura has extensive experience of regulatory and organisational transformation through her wider policy and operational work in other major government departments.
She joined the Medicines and Healthcare products Regulatory Agency from the Department of Health and Social Care in 2021, where she worked extensively on the COVID-19 vaccine deployment programme.
Within the HQ&A portfolio is the work to reform the regulatory framework for Medical Devices in the UK. Because of the priority of this work, for device patient access in the UK, and achievement of the UK Life Sciences Vision, Laura has been seconded to focus solely on this work. This includes leading interactions with IMDRF, and our Software and AI team who have a very productive partnership with the FDA Digital Centre of Excellence.
Laura started her career as a post-doctoral research assistant looking at resistance to anti-malarial drugs at the Liverpool Institute of Tropical Medicine following her PhD and BSc in Biochemistry and Physiology. She has spent most of her career as a Civil Servant. After many years in operational work Laura moved into government policy in 2014. In parallel, she went back to university, gaining an Executive Master’s degree in Public Policy from the London School of Economics. Laura has extensive experience of regulatory and organisational transformation through her wider policy and operational work in other major government departments.
She joined the Medicines and Healthcare products Regulatory Agency from the Department of Health and Social Care in 2021, where she worked extensively on the COVID-19 vaccine deployment programme.
Speaking At
